Singapore markets closed
  • Straits Times Index

    3,287.95
    +5.98 (+0.18%)
     
  • S&P 500

    4,662.85
    +3.82 (+0.08%)
     
  • Dow

    35,911.81
    -201.79 (-0.56%)
     
  • Nasdaq

    14,893.75
    +86.95 (+0.59%)
     
  • BTC-USD

    42,864.52
    -240.34 (-0.56%)
     
  • CMC Crypto 200

    1,029.63
    +3.90 (+0.38%)
     
  • FTSE 100

    7,597.81
    +54.86 (+0.73%)
     
  • Gold

    1,820.50
    +4.00 (+0.22%)
     
  • Crude Oil

    83.98
    +0.16 (+0.19%)
     
  • 10-Yr Bond

    1.7720
    +0.0610 (+3.57%)
     
  • Nikkei

    28,333.52
    +209.24 (+0.74%)
     
  • Hang Seng

    24,218.03
    -165.29 (-0.68%)
     
  • FTSE Bursa Malaysia

    1,542.92
    -12.41 (-0.80%)
     
  • Jakarta Composite Index

    6,645.05
    -48.35 (-0.72%)
     
  • PSE Index

    7,223.83
    -37.51 (-0.52%)
     

Global Liquid Biopsy Market Outlook 2021-2025: Growing Focus on Personalized Medicine for Cancer Care Driving Growth - ResearchAndMarkets.com

·2-min read

DUBLIN, December 02, 2021--(BUSINESS WIRE)--The "Global Liquid Biopsy Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

The liquid biopsy market is forecast to grow by $1.46 billion during 2021-2025, progressing at a CAGR of 18.73% during the forecast period.

The report on the liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as key vendor analysis.

The market is driven by increasing incidence of cancer and the growing focus on personalized medicine for cancer care. This study identifies the increasing focus on early detection of cancer as one of the prime reasons driving the liquid biopsy market growth during the next few years.

The liquid biopsy market analysis includes the technology segment and geographic landscape.

The liquid biopsy market is segmented as below:

By Technology

  • CTC and ctDNA

  • Exosome and RNA

By Geographical Landscape

  • North America

  • Europe

  • Asia

  • ROW

Key Topics Covered:

Market Landscape

  • Market ecosystem

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2020

  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

Market Segmentation by Technology

  • Market segments

  • Comparison by Technology

  • CTC and ctDNA - Market size and forecast 2020-2025

  • Exosome and RNA - Market size and forecast 2020-2025

  • Market opportunity by Technology

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2020-2025

  • Europe - Market size and forecast 2020-2025

  • Asia - Market size and forecast 2020-2025

  • ROW - Market size and forecast 2020-2025

  • Key leading countries

  • Market opportunity By Geographical Landscape

  • Market drivers

  • Market challenges

  • Market trends

Vendor Landscape

  • Overview

  • Landscape disruption

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • ANGLE Plc

  • Bio Techne Corp.

  • Biocept Inc.

  • CIRCULOGENE

  • F. Hoffmann-La Roche Ltd.

  • Guardant Health Inc.

  • LungLife AI Inc.

  • Myriad Genetics Inc.

  • QIAGEN NV

  • SAGA Diagnostics AB

For more information about this report visit https://www.researchandmarkets.com/r/4ed9gc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211202005401/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting